Oral cancer
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Michael Maddaleni, B.S., Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Synonyms and keywords: Squamous cell carcinoma of mouth; Oral carcinoma; Carcinoma-in-situ of oral mucosa; Verrucous carcinoma of oral cavity
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
Oral cancer (or mouth cancer) is a type of head and neck cancer that involves any cancerous tissue growth located in the oral cavity. Oral cancer is a malignant growth that affects any part of the oral cavity, including the lips, gums, tongue, inside lining of the cheeks, roof of the mouth and floor of the mouth. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types.
Classification
Oral cancer can be classified into three types based on the potential to spread to other parts of the body such as malignant tumors,precancerous conditions, and benign tumors. Most common type of malignant tumor of the mouth is squamous cell carcinoma. Squamous cell carcinoma is further classified by macroscopic and microscopic features. About 5% of oral cavity cancers are rare, malignant tumors that start in different types of cells in the oral cavity. These include: salivarygland cancer, melanoma, bone and soft tissue sarcomas, lymphomas and extramedullary plasmacytomas, hodgkin lymphoma, and non-Hodgkin lymphoma metastatic cancer.
Pathophysiology
It is understood that oral cancer occurs as a the result of carcinogen-metabolizing enzymes, alcohol, tobacco and genetic factors. Cytotoxic enzymes, such as alcohol dehydrogenase, result in the production of free radicals and DNA hydroxylated bases. Alcohol dehydrogenase oxidizes ethanol to acetaldehyde, which is cytotoxic in nature. Cigarette smoke has various carcinogens that can lead to oral cancers. Low-reactive, free radicals in cigarette smoke interact with redox-active metals in saliva. The development of oral cancer is the result of multiple genetic mutations. These mutations occur in tumor suppressor genes (TSGs) and oncogenes. Squamous cell carcinoma is the most common malignancy of the oral cavity. It typically has three gross morphological growth patterns: exophytic, ulcerative, and infiltrative. Microscopically, oral cancers are broadly based and invasive through papillary fronds. Oral cancer constitutes of highly differentiated squamous cells lacking frank cytologic criteria of malignancy with rare mitoses.The surface of the lesion is covered with compressed invaginating folds of keratin layers. A stroma-like inflammatory reaction and a blunt pushing margin may be seen
Causes
Common causes of oral cancers include pre-malignant lesion, tobacco, alcohol, human papillomavirus, and hematopoietic stem cell transplantation. Seventy-five percent of oral cancer cases occur due to tobacco. It causes irritation of the mucous membrane in the mouth. HPV type 16 is the most common sub-type of human papilloma virus associated with oral cancer.
Differentiating Oral cancer from other diseases
Oral cancer must be differentiated from actinic keratosis, dermatologic manifestations of oral leukoplakia, erythroplasia, lichen planus, and mucosal candidiasis.
Epidemiology and Demographics
The prevalence of oral cancer is estimated to be 91, 200 cases annually. The incidence of oral cancer is approximately 10.5 adults per 100,000 individuals worldwide, with a mortality rate of 1.2 per 100,000 individuals each year. Males are more commonly affected by squamous cell cancer of the oral cavity than females. The male to female ratio is approximately 6 to 1. Females are more commonly affected with adenocarcinoma of the hard palate. Oral cavity cancer more commonly affects individuals of the black population. Oral cavity cancer typically affects individuals of the lower-income patients.
Risk factors
The most potent risk factor in the development of oral cancer is alcohol intake and tobacco use. The other risk factors include male gender, age over 55 years, ultraviolet light, Fanconi anemia, dyskeratosis congenita, HPV infection, graft-versus-host disease (GVHD), mouthwash and irritation from dentures.
Screening
There is insufficient evidence to recommend routine screening for oral cancer.
Natural History, Complications and Prognosis
If left untreated, patients with oral cancer may progress to develop non-healing ulcer, which demonstrates growth over time. A neck mass may develop, possibly causing a mass defect. Depending on the extent of the tumor at the time of diagnosis, the prognosis varies. The 5-year survival rate for oral cancer diagnosed early is 75% compared to 20% for oral cancer diagnosed late. Complications of oral cancer include difficulty speaking, dysphagia , weight loss, bleeding and even death.
Staging
According to the TNM staging system by the American Joint Committee on cancer, there are four stages of oral cancer based on the tumor size, lymph nodes involved, and metastasis.
History and Symptoms
A positive history of tobacco chewing or smoking, excessive alcohol intake, poor oral hygiene, metallic denture, betel quid use, diet rich in meats and HPV infection in sexual partner is suggestive of oral cancer. The most common symptoms of oral cancer include a sore, irritated lump or thick patch in the mouth, lip, or throat; a white or red patch in the mouth; persistent mouth pain; a lump in the neck; loose tooth; bleeding in the mouth; pain in one ear without hearing loss; weight loss, etc.
Physical Examination
Common physical examination findings of oral cancer include a lump or thickening in the oral soft tissues, soreness, difficulty chewing or swallowing, ear pain, difficulty moving the jaw or tongue, hoarseness, numbness of the tongue or swelling of the jaw that causes dentures to fit poorly.
Laboratory Findings
Some patients with oral cancer may have elevated liver function tests, abnormal urea and electrolyte measurements, elevated calcium levels. Serum ferritin, alpha-anti-trypsin, and alpha-anti-glycoprotein levels may be increased in high-stage cancer of oral cavity; while those at any stage of the disease will have increased haptoglobin levels. Prealbumin levels are decreased slightly in persons at any stage.
X-ray
There are no x-ray findings associated with oral cancer. However, a chest x-ray may be helpful to diagnose metastases in the lungs, a site for second primary carcinoma and metastasis in hilar lymph nodes, ribs, or vertebrae. Jaw radiography may show invasion but may be inadequate to exclude bone invasion.
CT
Neck CT scans may be helpful in the diagnosis of oral cancer. CT scans can provide information about the size, shape and position of any tumor and may help identify enlarged lymph nodes.
MRI
Neck MRI’s may be helpful in the diagnosis of oral cancer. MRI’s can provide detailed view of cancer spread. Magnetic resonance imaging offers an advantage over computed tomographic scans in the detection and localization of head and neck tumors and in the distinction of lymph nodes from blood vessels.
Other Imaging Findings
A PET scan may be diagnostic of spread of oral cancer. FDG-PET (18-fluorodeoxyglucose positron emission tomography) scanning is useful to identify the extent of cervical node metastasis.
Other Diagnostic Studies
Biopsy of the tumor tissue is diagnostic of oral cancer. Other diagnostic studies for oral cancer include endoscopy, indirect pharyngoscopy, laryngoscopy, exfoliative cytology, barium swallow, chest x-ray and bone scan.
Medical Therapy
The predominant therapy for oral cancer is surgical resection, radiation therapy, or a combination of both. Adjunctive chemotherapy, radiation, chemotherapy may be required. Radiation in the form of external-beam radiation therapy (EBRT) or interstitial implantation is used. Advantages of radiotherapy are that normal anatomy or function are maintained, and general anesthesia is not needed. Disadvantages of radiotherapy are that it is inefficient to treat large tumors, subsequent surgery is more difficult, oral mucositis, dry mouth (xerostomia), osteoradionecrosis (ORN) etc.
Surgery
Surgery is the mainstay of treatment for oral cancer. Surgical resection of full-extent of the oral cavity lesion should be done. Only surgical resection is done when oral cancer has been detected early but not yet metastasized. In advanced-stages and recurrent cancers, surgery is done in combination with radiation therapy, chemotherapy or targeted therapy. Depending on the stage of oral cancer, one or more of the various procedures listed are recommended: Tumor resection, mohs micrographic surgery, full or partial mandible resection, glossectomy, maxillectomy, Laryngectomy, Neck dissection, partial or selective neck dissection, modified radical neck dissection or radical neck dissection.
Primary Prevention
Effective measures for the primary prevention of oral cancer include tobacco cessation, alcohol cessation, HPV vaccine, and avoiding excessive sun exposure.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
Hippocrates described the term “aphthae” in relation to the disorders of mouth in 370-460 B.C. By 1928, V. P. Blair of St. Louis was the first to advocate surgery as the best management for oral cancers. Cytotoxic chemotherapy was a major initiative in the 1970’s for the patients unfit for surgeries.
Oral cancer historical perspective
- Between 370-460 B.C., in relation to disorders of the mouth the term “aphthae” was first used by Hippocrates.[1]
- In 1838, the term melanoma was first proposed by Sir Robert Carswell, a British pathologist.[2]
- In 1875, Bernard von Langenbeck respected the ramus of the mandible in continuity with the primary tumor.[3]
- By 1928, V. P. Blair of St. Louis was the first to advocate surgery as the best management for oral cancers.
- A major initiative of the 1970’s and 1980’s was cytotoxic chemotherapy for patients unfit for surgeries.
- Verrucous carcinoma was first discovered in 1948 by Lauren V. Ackerman, an American physician.[4]
References
- ↑ Ship, Jonathan A. “Recurrent aphthous stomatitis: an update.” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 81.2 (1996): 141-147.
- ↑ Karamanou M, Liappas I, Stamboulis E, Lymperi M, Kyriakis K, Androutsos G (2012). “Sir Robert Carswell (1793-1857): coining the term “melanoma““. J BUON. 17 (2): 400–2. PMID 22740229.
- ↑ Alberti PW (1975). “Panel discussion: the historical development of laryngectomy. II. The evolution of laryngology and laryngectomy in the mid-19th century”. Laryngoscope. 85 (2): 288–98. doi:10.1288/00005537-197502000-00006. PMID 1089857.
- ↑ Lauren Ackerman. Wikipedia. https://en.wikipedia.org/wiki/Lauren_Ackerman. Accessed on May 11, 2016
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
Oral cancer can be classified into three types based on the potential to spread to other parts of the body such as malignant tumors,precancerous conditions, and benign tumors. Most common type of malignant tumor of the mouth is squamous cell carcinoma. Squamous cell carcinoma is further classified based on macroscopic and microscopic features. About 5% of oral cavity cancers are rare malignant tumors that start in different types of cells in the oral cavity. These include salivary gland cancer, melanoma, bone and soft tissue sarcomas, Lymphomas and extramedullary plasmacytomas, Hodgkin lymphoma, and non-Hodgkin lymphoma metastatic cancer.
Classification
(i) Malignant tumors of the oral cavity
- Malignant tumors of the oral cavity are cancerous growths that have the potential to spread (metastasize) to other parts of the body.
- The oral cavity is lined with squamous epithelium, which is formed by flat, scale-like cells called squamous cells.
- The most common oral cavity cancer starts in these cells and is called squamous cell carcinoma (SCC).
Squamous Cell Carcinoma
- Squamous cell carcinomas (SCC) make up 95% of all oral cavity cancers. They are classified based on macroscopic or microscopic features.
- Macroscopic features:
- Can be seen without a microscope
- Squamous cell carcinomas are described as following based on macroscopic features:
- Infiltrative – Cancer is growing into deep layers of the oral cavity
- Exophytic – Cancer is growing outwards from the surface of the oral cavity
- Verrucous– Cancer has a wart-like appearance
- Ulcerated– Cancer appears as an open sore
- Flat – Cancer appears as an abnormal area in the lining of the oral cavity
- Microscopic features:
- Squamous cell carcinomas (SCC) are further divided into the following types based on microscopic features:
- Classical or conventional SCC: Most cancers of the oral cavity are classical or conventional squamous cell carcinoma. This type of SCC starts in the squamous epithelium that lines the oral cavity and occurs most often on the lower lip, tongue and floor of the mouth.
- Variants of SCC: These squamous cell carcinomas have distinct microscopic features that make them look and behave differently from classical SCC.
- Verrucous carcinoma
- Basaloid SCC
- Papillary SCC
- Spindle cell carcinoma (SpCC)
- Acantholytic SCC
- Adenosquamous carcinoma
- Lymphoepithelial carcinoma
Rare malignant tumors
- About 5% of oral cavity cancers are rare, malignant tumors that start in different types of cells in the oral cavity.
- Salivary gland cancer
- Melanoma
- Bone and soft tissue sarcomas
- Lymphomas and extramedullary plasmacytomas
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Metastatic cancer
(ii) Pre-cancerous lesions of the oral cavity
- Several types of non-cancerous tumors and tumor-like conditions can arise in the oral cavity and oropharynx.
- A pre-malignant (or precancerous) lesion is defined as a benign, morphologically-altered tissue that has a greater than normal risk of becoming malignant.
- There are several different types of pre-malignant lesions that occur in the mouth.
- Some oral cancers begin as white patches (leukoplakia), red patches (erythroplakia), or mixed red and white patches (erythroleukoplakia or “speckled leukoplakia”).
- The most common pre-cancerous conditions of the oral cavity are:
- Leukoplakia
- Erythroplakia
- Erythroleukoplakia
- Proliferative verrucous leukoplakia (PVL)
- Oral submucous fibrosis
(iii) Benign tumors and conditions of the oral cavity
- Benign tumors: There are many different types of benign oral cavity tumors.
- Benign odontogenic tumors and cysts
- Benign conditions
- Candidiasis (thrush)
- Aphthous ulcers (canker sores)
- Recurrent herpes labialis (cold sores)
- Erythema migrans (geographic tongue)
- Hairy tongue
- Lichen planus
- Frictional hyperkeratosis
- Mucocele
TNM Classification of oral cavity carcinoma
The TNM classification of oral cavity carcinoma is as follows:[1]
| TNM Staging for Lip and Oral Cavity Cancers# | |
|---|---|
| Tumor | |
| TX | Primary tumor cannot be assessed |
| T0 | Primary tumor cannot be assessed |
| Tis | Carcinoma in situ |
| T1 | Tumor <2 cm or less in greatest dimension |
| T2 | Tumor more than 2 cm but not more than 4 cm in greatest dimension |
| T3 | Tumor more than 4 cm in greatest dimension |
| T4 (lip) | Tumor invades through cortical bone, inferior alveolar nerve, floor of the mouth, or skin of the face (e.g., chin or nose) |
| T4a (oral cavity) | Tumor invades adjacent structures (e.g., through cortical bone into deep [extrinsic] muscle of the tongue [[[genioglossus]], hyoglossus, palatoglossus, and styloglossus], maxillary sinus, or skin of the face) |
| T4b | Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid canal |
| Regional Lymph Nodes (N) | |
| NX | Regional lymph nodes cannot be assessed |
| N0 | No regional lymph node metastasis |
| N1 | Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension |
| N2a | Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension |
| N2b | Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension |
| N2c | Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension |
| N3 | Metastasis in a lymph node more than 6 cm in greatest dimension |
| Distant Metastasis (M) | |
| MX | Distant metastasis cannot be assessed |
| M0 | No distant metastasis |
| M1 | Distant metastasis |
| M = Distant metastasis; N = regional lymph nodes; T= primary tumor; Tis = carcinoma in situ.
# = Staging system of the American Joint Committee on Cancer. | |
| Staging of Oral Squamous Cell Carcinoma | |
|---|---|
| Stage | Description |
| 0 | Tis, N0, M0 |
| I | T1, N0, M0 |
| II | T2, N0, M0 |
| III | T3, N0, M0
T1, N1, M0 T2, N1, M0 T3, N1, M0 |
| IVA | T4a, N0, M0
T4a, N1, M0 T1, N2, M0 T2, N2, M0 T3, N2, M0 T4a, N2, M0 |
| IVB | Any T, N3, M0
T4b, any N, M0 |
| IVC | Any T, any N, M1 |
| M = Distant metastasis; N = regional lymph nodes; T = primary tumor; Tis = carcinoma in situ. | |
References
- ↑ Sobin, L. H. (2009). TNM classification of malignant tumours. Chichester, West Sussex, UK Hoboken, NJ: Wiley-Blackwell. ISBN 9781444332414.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
It is understood that oral cancers occur as a the result of carcinogen–metabolizing enzymes, alcohol, tobacco and genetic factors. Cytotoxic enzymes such as alcohol dehydrogenase result in the production of free radicals and hydroxylation of DNA base units. Alcohol dehydrogenase oxidizes ethanol to acetaldehyde which is cytotoxic in nature. Cigarette smoke has various carcinogens, which can lead to oral cancers. Low-reactive free radicals in cigarette smoke interact with redox-active metals in saliva.The development of oral cancer is the result of multiple genetic mutations. These mutations occur in tumor suppressor genes (TSGs) and oncogenes. Squamous cell carcinoma is the most common malignancy of the oral cavity. It typically has three gross morphological growth patterns, which are exophytic, ulcerative, and infiltrative. Microscopically, oral cancers are broadly based and invasive through papillary fronds. Oral cancer consists of highly differentiated squamous cells lacking frank cytologic criteria of malignancy with rare mitoses.The surface of the lesion is covered with compressed invaginating folds of keratin layers. A stroma-like inflammatory reaction and a blunt pushing margin may be seen.
Pathophysiology
It is understood that oral cancer occurs as a the result of carcinogen–metabolizing enzymes, alcohol, tobacco and genetic factors.
Carcinogen-metabolizing enzymes
- Carcinogen–metabolizing enzymes are known to cause cancer in some patients.
- Cytotoxic enzymes such as alcohol dehydrogenase result in the production of:
- Free radicals
- DNA hydroxylated bases
- These cytotoxic enzymes dominantly play a key role in the development of oral squamous cell carcinoma.
Alcohol
- Alcohol dehydrogenase oxidizes ethanol to acetaldehyde, which is cytotoxic in nature.
- Cytochrome P450 IIEI (CYP2E1) also metabolizes ethanol to acetaldehyde.
- Alcohol dehydrogenase type 3 genotype predisposes to oral squamous cell carcinoma.
- Carcinogenic potential increases when combined with tobacco use.
Tobacco
- Cigarette smoke has various carcinogens, which can lead to oral cancers.
- Low reactive free radicals in cigarette smoke interact with redox-active metals in saliva.
- saliva then looses its antioxidant potential and becomes a potent pro-oxidant milieu.[1]
Pathology of classical or conventional squamous cell carcinoma
- Most cancers of the oral cavity are classical or conventional squamous cell carcinoma.
- This type of SCC starts in the squamous epithelium, which lines the oral cavity and occurs most often on the lower lip, tongue and floor of the mouth.
- The microscopic features of classical SCC involve
- Keratin pearls
- These are circular layers of squamous cells that surround keratin (a tough fibrous protein).
- Keratin pearls
- Cancer starts in the squamous cells of the epithelium, and then invades the deeper layers of the oral cavity.
Pathology of squamous cell carcinoma variants
- The following squamous cell carcinomas have distinct microscopic features that make them look and behave differently from classical SCC:
- Verrucous carcinoma
- These tumors make up less than 5% of all oral cavity tumors.
- They have a wart-like appearance and develop most often on the gums (gingiva), lining of the cheeks (buccal mucosa) and larynx.
- Verrucous carcinomas are low grade, slow-growing and rarely spread.
- They are associated with the chronic use of snuff or chewing tobacco.
- Basaloid SCC
- This is a rare but aggressive sub-type of squamous cell carcinoma.
- It is more common in men older than 60 years old.
- Papillary SCC
- This is a rare sub-type of squamous cell carcinoma that grows outward from the surface of the epithelium (exophytic).
- HPV infections may have a role in the development of this type of cancer.
- Spindle cell carcinoma (SpCC)
- This is an aggressive, rare variant of squamous cell carcinoma.
- These tumors contain a mixture of conventional squamous cell carcinoma and spindle cells that resemble a sarcoma.
- It is also known as sarcomatoid carcinoma, pseudosarcoma, carcinosarcoma, pleomorphic carcinoma, metaplastic carcinoma, collision tumor and Lane tumor.
- Acantholytic SCC
- This is a rare variant of SCC in which the connections between the malignant squamous cells are broken down.
- This results in microscopic spaces in the tumor tissue, which appear like glands or vascular spaces.
- Adenosquamous carcinoma
- Lymphoepithelial carcinoma
- This is a rare sub-type of squamous cell carcinoma.
- The microscopic appearance is similar to undifferentiated nasopharyngeal carcinoma.
- It is also known as undifferentiated carcinoma.
Genetics
- The development of oral cancer is the result of multiple genetic mutations.
- These mutations include:
- Tumor suppressor genes (TSGs)
- Oncogenes
Tumor suppressor genes (TSGs)
- Oral cavity cancer may be the result of an allelic imbalance, which is caused by chromosomal changes- particularly in chromosome 3, 9, 11 and 17.
- These changes lead to mutation in tumor suppressor genes (TSGs).
- In non-cancerous situations, TSGs modulate normal growth.
- Mutation of these TSGs lead to dysfunctional growth control.
- Mutation most commonly occurs in one of the following:
- Short arm of chromosome 3
- TSG termed P16 on chromosome 9
- TSG termed TP53 on chromosome 17
- The Cytochrome P450 genotype is related to mutations in some TSGs and leads to oral squamous cell carcinoma.
- In western countries (eg. United Kingdom, United States, or Australia), TP53 mutations are the most common molecular change that leads to oral squamous cell carcinoma.
Oncogenes
- Cancer may also occur if there is mutation in other genes that control cell growth, typically oncogenes.
- Oncogenes most commonly involved are:
- Chromosome 11 (PRAD1)
- Chromosome 17 (Harvey ras [H-ras])
- In eastern countries (eg. India or Southeast Asia), ras oncogenes is a more common cause of oral squamous cell carcinoma.
Gross Pathology
- Squamous cell carcinoma is the most common malignancy of the oral cavity.
- It typically has three gross morphological growth patterns, which are exophytic, ulcerative, and infiltrative.
- The infiltrative and ulcerative are the growth patterns most commonly observed in the oral cavity.
- The macroscopic appearance of oral cancer depends on the following:
- Duration of the lesion
- The amount of keratinization
- The changes in the adjoining mucosa
- A fully developed oral cavity lesion appears as an exophytic bulky lesion that is gray to grayish-red and has a rough, shaggy, or papillomatous surface

Microscopic Pathology
- Microscopically, oral cancers are broadly based and invasive through papillary fronds.
- Oral cancer constitutes of highly-differentiated squamous cells lacking frank cytologic criteria of malignancy with rare mitoses.
- The surface of the lesion is covered with compressed invaginating folds of keratin layers.
- A stroma-like inflammatory reaction and a blunt pushing margin may be seen.
- SCC is subdivided by the WHO into:[2]

References
- ↑ Nagler R, Dayan D (2006). “The dual role of saliva in oral carcinogenesis”. Oncology. 71 (1–2): 10–7. doi:10.1159/000100445. PMID 17344667.
- ↑ Peterson BR, Nelson BL (2013). “Nonkeratinizing undifferentiated nasopharyngeal carcinoma”. Head Neck Pathol. 7 (1): 73–5. doi:10.1007/s12105-012-0401-4. PMC 3597164. PMID 23015393.
- ↑ Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N (1995). “Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia”. Am J Pathol. 146 (6): 1355–67. PMC 1870892. PMID 7778675.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
Common causes of oral cancers include premalignant lesions, tobacco, alcohol, human papillomavirus, and hematopoietic stem cell transplantation. Tobacco use is the cause of 75% oral cancer cases . It causes an irritation of mucous membrane in the mouth. HPV type 16 is the most common sub-type of human papilloma virus associated with oral cancer.
Causes
Common causes of oral cancer include:
- Pre-malignant lesion[1]
- Benign and morphologically-altered tissue
- Pre-malignant lesions are of various types:
- Leukoplakia – benign white patches
- Erythroplakia – red patches
- Erythroleukoplakia – mixed red and white patches
- Lichen planus
- Oral sub-mucous fibrosis – very common in Indian sub-continents
- actinic cheilitis
- Tobacco
- 75% cases of oral cancers occur due to tobacco use.
- Use of it causes irritation of the mucous membrane in the mouth.
- Both smoking and chewing tobacco can lead to irritation of mucous membrane of the mouth.
- 60 types of carcinogens are known to be present in tobacco smoke.
- If any form of tobacco use is combined with heavy alcohol intake, the carcinogenic potential increases.
- Alcohol[2]
- Heavy alcohol intake can lead to cancer of pharynx and larynx.
- Carcinogenic potential increases when combined with tobacco use.
- Hematopoietic stem cell transplantation
- This causes an increased risk for squamous cell carcinoma.
References
- ↑ Colvin RB, Pinn VW, Simpson BA, Dvorak HF (1973). “Cutaneous basophil hypersensitivity. IV. The “late reaction”: sequel to Jones-Mote type hypersensitivity. Comparison with rabbit Arthus reaction. Effect of passive antibody on induction and expression of Jones-Mote hypersensitivity”. J. Immunol. 110 (5): 1279–89. PMID 4266835.
- ↑ Stornetta A, Guidolin V, Balbo S (2018). “Alcohol-Derived Acetaldehyde Exposure in the Oral Cavity”. Cancers (Basel). 10 (1). doi:10.3390/cancers10010020. PMID 29342885.
- ↑ Shah A, Malik A, Garg A, Mair M, Nair S, Chaturvedi P (2017). “Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature”. Postgrad Med J. 93 (1105): 704–709. doi:10.1136/postgradmedj-2016-134603. PMID 28778951.
Differentiating Oral cancer from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
There are different types of cancers of the oral cavity and oropharynx. It is important that they are differentiated from one another.
Oral cancer differential diagnosis
The table below outlines the different types of tumors/cancers present in the oral cavity and oropharynx and how they can be differentiated from one another.
| Type of cancer | Subtype | ICD-O Code | Epidemiology | Etiology | Localization | Clinical features | Diagnostic procedures |
|---|---|---|---|---|---|---|---|
Squamous cell carcinoma
|
Verrucous carcinoma | 8051/3 |
|
|
|
|
Biopsy shows:
Thickened club-shaped papillae and blunt stromal invaginations of well-differentiated squamous epithelium with marked keratinization |
| Lymphoepithelial carcinoma | 8082/3 | 0.8-2% of all oral or oropharyngeal cancers | EBV |
|
|
Biopsy chows:
| |
| Epithelial precursor lesions | — | — | — | Smoking | Seen in the entire digestive tract |
|
Biopsy shows:
|
| Proliferative verrucous leukoplakia and precancerous conditions | — | — |
|
Unknown |
|
An aggressive form of oral leukoplakia with considerable morbidity and strong predilection to malignant transformation | Biopsy shows:
|
| Papillomas | Squamous cell papilloma and |
|
HPV sub-types
2, 4, 6, 7,10, and 40 |
Any oral site may be affected mostly:
|
Soft, pedunculated lesions formed by a cluster of finger-like fronds or a sessile, dome-shaped lesion with a nodular, papillary or verrucous surface | Biopsy shows:
| |
| Condyloma acuminatum | 2nd and 5th decade with a peak in teenagers and young adults |
|
|
Biopsy shows:
Several sessile, cauliflower-like swellings forming a cluster | |||
| Focal epithelial hyperplasia | — | Disease of children, adolescents and young adults | HPV sub types:
13 and 32 |
|
|
Biopsy shows:
| |
| Granular cell tumor | — | 9580/0 |
|
No etiological factors are known |
|
|
Biopsy shows:
|
| Keratoacanthoma | — | 8071/1 |
whites
men as in women |
Associated with uptake of carcinogens (e.g. via particular smoking habits) |
|
|
Biopsy shows:
|
| Papillary hyperplasia | — | — | Affects all age groups | Associated with:
|
Palate | Asymptomatic nodular or papillary mucosal lesion | Biopsy shows:
|
| Median rhomboid glossitis | — | — | — | Associated with chronic candidal infection | Dorsum of the tongue at the junction of the anterior two-thirds
and posterior third |
Forms a patch of papillary atrophy in the region of the
embryological foramen caecum |
Biopsy shows:
|
| Salivary gland tumors | Acinic cell carcinoma | 8550/3 |
|
Unknown | Tumors usually
form non-descript swellings |
Biopsy shows:
| |
| Mucoepidermoid carcinoma | 8430/3 |
|
Unknown |
|
|
Low power microscopy shows low-grade tumor with both cystic and solid areas and an inflamed, fibrous stroma | |
| Adenoid cystic carcinoma | 8200/3 |
|
Unknown |
|
Predominantly solid variant shows peri- and intraneural invasion | ||
| Epithelial-myoepithelial
carcinoma |
8562/3 | — | Unknown | — | — | — | |
| Clear cell carcinoma,
NOS |
8310/3 | Unknown | — | — | — | ||
| Basal cell | 8147/3 | Rare in minor glands | Unknown | Asymptomatic, smooth or lobulated sub-mucosal masses | Microscopically similar to basal cell adenocarcinomas of the major gland | ||
| Cystadenocarcinoma | 8450/3 | 32% developed in the minor glands | Unknown |
|
Slow growing and painless but somepalatal tumors may erode the underlying bone-causing sinonasal complex | — | |
| Salivary duct carcinoma | 8500/3 |
|
Unknown |
|
Tumors form painless swellings but many in the palate can be painful and ulcerated or fungated withmetastases to regional lymph nodes | The range of
microscopical appearances is similar to that seen in the major glands | |
| Salivary gland adenomas | Pleomorphic adenoma | 8940/0 | 40-70% of minor gland tumors | Unknown | Painless, slow-growing, submucosal masses, but when traumatized may bleed or ulcerate | Biopsy shows cellular, and hyaline or plasmacytoid cell | |
| Myoepithelioma | 8982/0 | 42% of minor gland tumors | Unknown |
|
— | — | |
| Basal cell adenoma | 8147/0 | 20% of minor gland tumors | Unknown | — | They are histologically
similar to those in major glands. | ||
| Cystadenoma | 8149/0 | 7% of benign minor gland tumors | Uknown | — | — | ||
| Kaposi sarcoma | — | — |
|
|
|
Biopsy of all 4 types show:
| |
| Lymphangioma | — | 9170/0 |
|
Tongue |
|
Biopsy shows:
| |
| Ectomesenchymal chondromyxoid
tumour of the anterior tongue |
— | — |
|
Unknown | — | Asymptomatic, slow growing solitary nodule in the anterior dorsal tongue | Biopsy shows:
|
| Focal oral mucinosis (FOM) | — | — |
|
Unknown | Asymptomatic fibrous or cystic-like lesion | Histopathology is characterized by:
| |
| Congenital granular cell epuli | — | — |
|
Etiology uncertain | Solitary, somewhat edunculated fibroma-like lesion, attached to the alveolar ridge near the mid-line | ||
| Hematolymphoid tumors | Non-Hodgkin lymphoma | — | Second most common cancer of the oral cavity |
|
|
NHL of the lip presents with:
|
Biopsy shows:
|
| Langerhans cell histiocytosis | 9751/1 | — | Associated with:
|
|
Common oral symptoms
include:
|
Biopsy shows ovoid Langerhans cells
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm | |
| Hodgkin lymphoma | — | Strongly associated with Epstein- Barr Virus |
|
Most patients present with localized disease (stage I/II), with
|
— | ||
| Extramedullary myeloid
sarcoma |
9930/3 | — | History of acute myeloid leukaemia,
predominantly in the monocytic or myelomonocytic sub-types |
Isolated tumor-forming intra-oral mass | Biopsy shows an Indian-file pattern of infiltration | ||
| Follicular dendritic cell
sarcoma / tumour |
9758/3 |
|
History of underlying hyaline-vascular Castleman disease | The patients usually present with a painless mass | Biopsy usually exhibits
borders and comprises:
| ||
| Mucosal malignant melanoma | — | 8720/3 |
|
No known etiological factors associated with oral melanoma | 80% arise:
Others:
|
|
|
References
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
The prevalence of oral cancer is estimated to be 91,200 cases annually. The incidence of oral cancer is approximately 10.5 adults per 100,000 individuals worldwide with a mortality rate of 1.2 per 100,000 individuals each year. Males are more commonly affected by squamous cell cancer of the oral cavity than females. The male to female ratio is approximately 6 to 1. Females are more commonly affected with adenocarcinoma of the hard palate. Oral cavity cancer usually affects individuals of the black population. Oral cavity cancer usually affects individuals of the lower-income patients.
Epidemiology and Demographics
Prevalence
- Oral cancer is the 11th most common malignancy, worldwide.[1]
- In the United States, it is estimated that approximately 91,200 persons are living with oral cancer.
- It is estimated that about 14% cancers of head and neck are oral cancers (excluding lip cancer).
Incidence
- The incidence of oral cancer is approximately 8.4 adults per 100,000 individuals worldwide with a mortality rate of 1.2 per 100,000 individuals each year.[2]
- From 2010 to 2014, the estimated age-adjusted incidence of cancer of the oral cavity and pharynx in the United States was 11.2 cases per 100,000 persons per year.[3]
- It is estimated that there will be 49,670 new cases of oral cavity and pharynx cancer diagnosed in the United States in 2017 and 9,700 deaths due to this disease.[4]
Gender
- Males are more commonly affected by squamous cell cancer of the oral cavity than females.[5]
- The male to female ratio is approximately 6:1.[5]
- Females are more commonly affected with adenocarcinoma of the hard palate.
Age
- The incidence of oral cavity cancer increases with age; the median age at diagnosis is 65 years.
Race
- Oral cavity cancer usually affects individuals of the black population.
- Oral cavity cancer usually affects individuals of the lower-income patients.
References
- ↑ Ghantous Y, Yaffi V, Abu-Elnaaj I (July 2015). “[Oral cavity cancer: epidemiology and early diagnosis]”. Refuat Hapeh Vehashinayim (1993) (in Hebrew). 32 (3): 55–63, 71. PMID 26548152.
- ↑ Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I (August 2015). “Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010”. Cancer Epidemiol. 39 (4): 497–504. doi:10.1016/j.canep.2015.04.007. PMC 4532587. PMID 25976107.
- ↑ “Oral Cavity and Oropharyngeal Cancer Prevention (PDQ®) – National Library of Medicine – PubMed Health”.
- ↑ “www.cancer.org” (PDF).
- ↑ 5.0 5.1 “Oral Cancer Incidence (New Cases) by Age, Race, and Gender | National Institute of Dental and Craniofacial Research”.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
The most potent risk factor in the development of oral cancer is alcohol intake and tobacco use. The other risk factors include male gender, age over 55 years, ultraviolet light, Fanconi anemia, dyskeratosis congenita, HPV infection, graft-versus-host disease (GVHD), mouthwash and irritation from dentures.
Risk Factors
Common risk factors
- The most potent risk factor in the development of oral cavity cancer is tobacco and alcohol use.
- Other risk factors include:
- Lifestyle
- Betel quid use[1]
- Genetics
- Lifestyle
- Infectious agents:
- General
- Male gender[5]
- Ultraviolet light[6]
- Age over 55 years[7]
- Graft-versus-host disease (GVHD)[8]
- Immune system suppression
- Lichen planus
Less common risk factors
- Less common risk factors for the development of oral cancer include:
References
- ↑ Su CC, Yang HF, Huang SJ, Lian I (2007). “Distinctive features of oral cancer in Changhua County: high incidence, buccal mucosa preponderance, and a close relation to betel quid chewing habit”. J. Formos. Med. Assoc. 106 (3): 225–33. PMID 17389167. Vancouver style error: initials (help)
- ↑ Martín-Hernán F, Sánchez-Hernández JG, Cano J, Campo J, del Romero J (May 2013). “Oral cancer, HPV infection and evidence of sexual transmission”. Med Oral Patol Oral Cir Bucal. 18 (3): e439–44. PMC 3668870. PMID 23524417.
- ↑ Kim SM (December 2016). “Human papilloma virus in oral cancer”. J Korean Assoc Oral Maxillofac Surg. 42 (6): 327–336. doi:10.5125/jkaoms.2016.42.6.327. PMC 5206237. PMID 28053902.
- ↑ Sanjaya PR, Gokul S, Gururaj Patil B, Raju R (December 2011). “Candida in oral pre-cancer and oral cancer”. Med. Hypotheses. 77 (6): 1125–8. doi:10.1016/j.mehy.2011.09.018. PMID 21978967.
- ↑ Muscat JE, Richie JP, Thompson S, Wynder EL (November 1996). “Gender differences in smoking and risk for oral cancer”. Cancer Res. 56 (22): 5192–7. PMID 8912856.
- ↑ De Benedittis M, Petruzzi M, Giardina C, Lo Muzio L, Favia G, Serpico R (November 2004). “Oral squamous cell carcinoma during long-term treatment with hydroxyurea”. Clin. Exp. Dermatol. 29 (6): 605–7. doi:10.1111/j.1365-2230.2004.01586.x. PMID 15550132.
- ↑ Ram H, Sarkar J, Kumar H, Konwar R, Bhatt ML, Mohammad S (June 2011). “Oral cancer: risk factors and molecular pathogenesis”. J Maxillofac Oral Surg. 10 (2): 132–7. doi:10.1007/s12663-011-0195-z. PMC 3177522. PMID 22654364.
- ↑ de Araújo RL, Lyko Kde F, Funke VA, Torres-Pereira CC (2014). “Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease”. Rev Bras Hematol Hemoter. 36 (1): 65–8. doi:10.5581/1516-8484.20140016. PMC 3948669. PMID 24624039.
- ↑ Rosenquist K, Wennerberg J, Schildt EB, Bladström A, Göran Hansson B, Andersson G (2005). “Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden”. Acta Otolaryngol. 125 (12): 1327–36. doi:10.1080/00016480510012273. PMID 16303683.
- ↑ Scully C (2002). “Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission”. Oral Oncol. 38 (3): 227–34. PMID 11978544.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
There is insufficient evidence to recommend routine screening for oral cancer.
Screening
- There is insufficient evidence to recommend routine screening for oral cancer.[1]
- There is no country that has any routine screening program for oral cancer.
- There is insufficient evidence to support any screening modality that might decrease mortality in oral cancer.
References
- ↑ Speight, Paul M.; Epstein, Joel; Kujan, Omar; Lingen, Mark W.; Nagao, Toru; Ranganathan, Kannan; Vargas, Pablo (2017). “Screening for oral cancer—a perspective from the Global Oral Cancer Forum”. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 123 (6): 680–687. doi:10.1016/j.oooo.2016.08.021. ISSN 2212-4403.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
If left untreated, patients with oral cancer may progress to develop a non-healing ulcer, which demonstrates growth over time. A neck mass may develop, which may cause a mass defect. Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. The 5-year survival rate for oral cancer that is diagnosed early is 75%, compared to 20% for late diagnosis. Complications of oral cancer include difficulty speaking, dysphagia, weight loss, bleeding and even death.
Natural History
- Oral cancers usually present late, as they are usually painless and often ignored by the patient.
- Eventually they present as a non-healing ulcer, which demonstrates growth over time.
- Due to the extensive lymphatic drainage of the oral cavity, nodal metastases are common at the time of diagnosis.
- A neck mass may be the presenting complaint.
- Because of the difficulties with direct visualization, they may extend into the tongue or have clinical lymph node metastases before the diagnosis is established.
- As the tumors enlarge, they may cause a mass effect, which can lead to respiratory compromise when the patient presents late in their illness.[1]
Prognosis
- The prognosis depends on the following:
- Stage of the cancer
- Number and size of lymph nodes with cancer
- HPV infection of the oropharynx
- Smoking history more than a ten pack-year
- 5-year survival rate for oral cancer:
- Diagnosed early – 75%
- Diagnosed late – 20%
- Localized disease at diagnosis – 83%
- Cancer spread to other parts of the body – 32%
- Cure rate:
- More than 50% oral cancers are diagnosed when they have spread to throat and neck.
Complications
- Direct surgical complications include infection, bleeding, aspiration, wound breakdown, flap loss, and fistula.
- Complications of chemotherapy includes the following:[1]
- Neurotoxicity– This complication is a side-effect of certain classes of drugs, such as the vinca alkaloids.
- Bleeding
- Complications of radiation therapy includes the following:[2]
- Complications common to both chemotherapy and radiation include the following:[3]
- Oral mucositis
- Chronic dysphagia
- Anemia
- Pharyngocutaneous fistula
- Aspiration
- Infections such as viral, bacterial, and fungal that results from myelosuppression, xerostomia, and damage to the mucosa from radiotherapy or chemotherapy
- Xerostomia
- Functional disabilities such as impaired ability to swallow, eat, taste and speak because of trismus, dry mouth, mucositis, and infection
- Nutritional compromise, such as poor nutrition from eating difficulties caused by dry mouth, mucositis, dysphagia, and loss of taste.
- Abnormal dental development
- Altered tooth development, craniofacial growth, or skeletal development in children- secondary to high doses of chemotherapy and radiotherapy before age 9
References
- ↑ Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA (1998). “Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients”. Otolaryngol Head Neck Surg. 118 (5): 616–24. doi:10.1177/019459989811800509. PMID 9591859.
- ↑ Gomez DR, Zhung JE, Gomez J, Chan K, Wu AJ, Wolden SL; et al. (2009). “Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers”. Int J Radiat Oncol Biol Phys. 73 (4): 1096–103. doi:10.1016/j.ijrobp.2008.05.024. PMID 18707827.
- ↑ Oh HK, Chambers MS, Martin JW, Lim HJ, Park HJ (2009). “Osteoradionecrosis of the mandible: treatment outcomes and factors influencing the progress of osteoradionecrosis”. J Oral Maxillofac Surg. 67 (7): 1378–86. doi:10.1016/j.joms.2009.02.008. PMID 19531406.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies | Staging
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
